Generation of human iPSCs from fetal prostate fibroblasts HPrF

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68081707%3A_____%2F19%3A00503128" target="_blank" >RIV/68081707:_____/19:00503128 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/19:00108162 RIV/61989592:15110/19:73594613 RIV/00159816:_____/19:00072539
Result on the web
<a href="https://doi.org/10.1016/j.scr.2019.101405" target="_blank" >https://doi.org/10.1016/j.scr.2019.101405</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.scr.2019.101405" target="_blank" >10.1016/j.scr.2019.101405</a>

Result language
angličtina
Original language name
Generation of human iPSCs from fetal prostate fibroblasts HPrF
Original language description
Human induced pluripotent stem cell line was generated from commercially available primary human prostate fibroblasts HPrF derived from a fetus, aged 18-24 weeks of gestation. The fibroblast cell line was reprogrammed with Yamanaka factors (OCT4, SOX2, c-MYC, KLF4) using CytoTune (TM)-iPS 2.0 Sendai Reprogramming Kit. Pluripotency of the derived transgene-free iPS cell line was confirmed both in vitro by detecting the expression of factors of pluripotency on a single-cell level, and in vivo using teratoma formation assay. This iPS cell line will be a useful tool for studying both normal prostate development and prostate cancer disease.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10601 - Cell biology

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)